Piper Sandler: Transformative License Transaction, Raised Aclaris (ACRS.US) target to $13

Market IntelTuesday, Nov 19, 2024 1:20 am ET

1min read

ACRS -1.19% PIPR -0.55%

Aclaris Therapeutics (ACRS.US) shares rose 53% to $3.14 on Monday after the biopharmaceutical company announced it had secured exclusive rights to two immunotherapy candidates from Biosion, prompting Piper Sandler to upgrade the company's rating.

Comments

Add a public comment...

Post

werewere223

11/19

While the surge is intriguing, I'm waiting for the dust to settle. Want to see if this momentum is more than just a flash in the pan. Might consider dipping my toes in if/when it dips slightly...

StephCurryInTheHouse

11/19

Just went from curious to invested in one day! The potential for these immunotherapy candidates is massive. ACRS is on my watchlist for good now. Welcome to the party!

MrJSSmyth

11/19

Thanks, Piper Sandler, for the upgrade, but let's not get ahead of ourselves. We'll believe it when we see consistent quarterly earnings. $13 is a lofty goal...

Longjumping_Rip_1475

11/19

Finally, some innovation in immunotherapy! The future of medicine is here and ACRS is at the forefront. Exciting times for biotech enthusiasts!

GJohannes37

11/19

53% rise in a day is ridiculous. Need to see sustained growth before I consider buying in. Not a bad company, just not a buy-high, sell-high kind of situation.

Senyorty12

11/19

Loving the surge! Piper Sandler knows what's up, $13 target is totally achievable, buying more shares today!

No More Comment

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.

You Can Understand News Better with AI.

Whats the News impact on stock market?

Its impact is

AInvest

Aime Coplilot

Invest Smarter With AI Power.

Open App